Hypoxia-dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression

Molecular Carcinogenesis

Volumn 53, Issue 11, 2014, Pages 883-892

  Hirschfeld, Marc ^a,b   Zhang, Bo ^a,c,d   Jaeger, Markus ^a   Stamm, Stefan ^e   Erbes, Thalia ^a   Mayer, Sebastian ^a   Tong, Xiaowen ^c   Stickeler, Elmar ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c TONGJI UNIVERSITY   (China)

^d St Elisabeth Hospital Bochum   (Germany)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

BRCA2; Cancer; Hypoxia; Splicing; YT521

Indexed keywords

CD44V ANTIGEN; MESSENGER RNA; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; HERMES ANTIGEN; ISOPROTEIN; MRFAP1 PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SIGNAL PEPTIDE; SMALL INTERFERING RNA; YTHDC1 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESR1 GENE; EXON; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MDM2 GENE; OVARY CANCER; PHENOTYPE; REPORTER GENE; RNA PROCESSING; RNA SEQUENCE; TUMOR SUPPRESSOR GENE; UPREGULATION; VEGF GENE; YT521 GENE; BIOSYNTHESIS; CELL HYPOXIA; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; MCF 7 CELL LINE; NEOPLASM; RNA INTERFERENCE; TUMOR CELL LINE;

ALTERNATIVE SPLICING; ANTIGENS, CD44; BRCA2 PROTEIN; CELL HYPOXIA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MCF-7 CELLS; NEOPLASMS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 84907951648     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22045     Document Type: Article

References (42)

1. Hartmann AM, Nayler O, Schwaiger FW, Obermeier A, Stamm S. The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59(fyn). Mol Biol Cell 1999; 10:3909-3926.
2. Imai Y, Matsuo N, Ogawa S, Tohyama M, Takagi T. Cloning of a gene, YT521, for a novel RNA splicing-related protein induced by hypoxia/reoxygenation. Brain Res 1998; 53:33-40.
3. Stamm S, Riethoven JJ, Le Texier V, et al. ASD: A bioinformatics resource on alternative splicing. Nucleic Acids Res 2006; 34: (Database issue):D46-D55.
4. Gardner LB. Nonsense-mediated RNA decay regulation by cellular stress: Implications for tumorigenesis. Mol Cancer Res 2010; 8:295-308.
5. Nayler O, Hartmann AM, Stamm S. The ER repeat protein YT521-B localizes to a novel subnuclear compartment. J Cell Biol 2000; 150:949-962.
6. Zhang Z, Theler D, Kaminska KH, et al. The YTH domain is a novel RNA binding domain. J Biol Chem 2010; 285:14701-14710.
7. Stoilov P, Rafalska I, Stamm S. YTH: A new domain in nuclear proteins. Trends Biochem Sci 2002; 27:495-497.
8. Rafalska I, Zhang Z, Benderska N, et al. The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation. Hum Mol Genet 2004; 13:1535-1549.
9. Zhang B, zur Hausen A, Orlowska-Volk M, et al. Alternative splicing-related factor Y T521: An independent prognostic factor in endometrial cancer. Int J Gynecol Cancer 2010; 20:492-499.
10. Harris AL. Hypoxia-A key regulatory factor in tumour growth. Nature Rev 2002; 2:38-47.
11. Hirschfeld M, zur Hausen A, Bettendorf H, Jager M, Stickeler E. Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer. Cancer Res 2009; 69:2082-2090.
12. Hirschfeld M, Jaeger M, Buratti E, et al. Expression of tumor-promoting Cyr61 is regulated by hTRA2-beta1 and acidosis. Hum Mol Genet 2011; 20:2356-2365.
13. Daoud R, Mies G, Smialowska A, Olah L, Hossmann KA, Stamm S. Ischemia induces a translocation of the splicing factor tra2-beta 1 and changes alternative splicing patterns in the brain. J Neurosci 2002; 22:5889-5899.
14. Hansson MD, Rzeznicka K, Rosenback M, Hansson M, Sirijovski N. PCR-mediated deletion of plasmid DNA. Anal Biochem 2008; 375:373-375.
15. Stickeler E, Fraser SD, Honig A, Chen AL, Berget SM, Cooper TA. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J 2001; 20:3821-3830.
16. Maquat LE. Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 2004; 5:89-99.
17. Carter MS, Doskow J, Morris P, et al. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem 1995; 270:28995-29003.
18. Asselta R, Rimoldi V, Guella I, et al. Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA. Blood 2010; 115:2065-2072.
19. Yeo G, Holste D, Kreiman G, Burge CB. Variation in alternative splicing across human tissues. Genome Biol 2004; 5:R74.
20. Ule J, Ule A, Spencer J, et al. Nova regulates brain-specific splicing to shape the synapse. Nat Genet 2005; 37:844-852.
21. Sugnet CW, Srinivasan K, Clark TA, et al. Unusual intron conservation near tissue-regulated exons found by splicing microarrays. PLoS Comput Biol 2006; 2:e4.
22. Lareau LF, Green RE, Bhatnagar RS, Brenner SE. The evolving roles of alternative splicing. Curr Opin Struct Biol 2004; 14:273-282.
23. Keren H, Lev-Maor G, Ast G. Alternative splicing and evolution: Diversification, exon definition and function. Nat Rev Genet 2010; 11:345-355.
24. Farrugia DJ, Agarwal MK, Pankratz VS, et al. Functional assays for classification of BRCA2 variants of uncertain significance. Cancer Res 2008; 68:3523-3531.
25. Garcia Pedrero JM, Zuazua P, Martinez-Campa C, Lazo PS, Ramos S. The naturally occurring variant of estrogen receptor (ER) ERDeltaE7 suppresses estrogen-dependent transcriptional activation by both wild-type ERalpha and ERbeta. Endocrinology 2003; 144:2967-2976.
26. Jeyaraj S, O'Brien DM, Chandler DS. MDM2 and MDM4 splicing: An integral part of the cancer spliceome. Front Biosci 2009; 14:2647-2656.
27. Matsuyama M, Chijiwa T, Inoue Y, et al. Alternative splicing variant of vascular endothelial growth factor-A is a critical prognostic factor in non-small cell lung cancer. Oncol Rep 2009; 22:1407-1413.
28. Cork DM, Lennard TW, Tyson-Capper AJ. Alternative splicing and the progesterone receptor in breast cancer. Breast Cancer Res 2008; 10:207.
29. Noman MZ, Messai Y, Carre T, et al. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response. Crit Rev Immunol 2011; 31:357-377.
30. Fukumura D, Xu L, Chen Y, Gohongi T, Seed B, Jain RK. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 2001; 61:6020-6024.
31. Kikuchi Y, Kakeya T, Nakajima O, et al. Hypoxia induces expression of a GPI-anchorless splice variant of the prion protein. FEBS J 2008; 275:2965-2976.
32. Lareau LF, Brooks AN, Soergel DA, Meng Q, Brenner SE. The coupling of alternative splicing and nonsense-mediated mRNA decay. Adv Exp Med Biol 2007; 623:190-211.
33. Liu L, Simon MC. Regulation of transcription and translation by hypoxia. Cancer Biol Ther 2004; 3:492-497.
34. Papandreou I, Powell A, Lim AL, Denko N. Cellular reaction to hypoxia: Sensing and responding to an adverse environment. Mutat Res 2005; 569:87-100.
35. Green RE, Lewis BP, Hillman RT, et al. Widespread predicted nonsense-mediated mRNA decay of alternatively-spliced transcripts of human normal and disease genes. Bioinformatics (Oxford, England) 2003; 19:i118-i121.
36. Wollerton MC, Gooding C, Wagner EJ, Garcia-Blanco MA, Smith CW. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol Cell 2004; 13:91-100.
37. Sureau A, Gattoni R, Dooghe Y, Stevenin J, Soret J. SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J 2001; 20:1785-1796.
38. Stoilov P, Daoud R, Nayler O, Stamm S. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum Mol Genet 2004; 13:509-524.
39. Hillman RT, Green RE, Brenner SE. An unappreciated role for RNA surveillance. Genome Biol 2004; 5:R8.
40. Ni JZ, Grate L, Donohue JP, et al. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev 2007; 21:708-718.
41. Mishra OP, Ashraf QM, Delivoria-Papadopoulos M. Tyrosine phosphorylation of neuronal nitric oxide synthase (nNOS) during hypoxia in the cerebral cortex of newborn piglets: The role of nitric oxide. Neurosci Lett 2009; 462:64-67.
42. Toby IT, Chicoine LG, Cui H, Chen B, Nelin LD. Hypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activation. Am J Physiol 2010; 298:L600-L606.